Collaborations
Avalanche collaborates with leading academic institutions and pharmaceutical companies who can augment our industry-leading expertise in gene therapy for the eye. Please contact us for more information.
Our Partners Include:
 |
EyeCRO is a preclinical ophthalmic research organization focused on retinal disease models, both in vivo and in vitro. Currently, EyeCRO offers models in the areas of ocular angiogenesis, retinal degeneration, retinal vascular permeability, safety, and pharmacokinetics. In addition, EyeCRO is adding new models every year. EyeCRO also offers its clients formulation services such as developing eye drop formulations, depot forming injectables, microparticles, PLGA nanoparticles, and fluorescent micro & nanoparticles to suit their needs. |
 |
In 1975 the Lions Save-Sight Foundation (LSSF) established the Lions Chair in Ophthalmology at the University of Western Australia (UWA). Professor Ian Constable AO was appointed to this position and subsequently established the Lions Eye Institute (LEI). As LEI's inaugural Managing Director, Professor Constable spearheaded its efforts to eradicate blindness worldwide. LEI conducts first class scientific research into blindness and incorporates one of Australia's largest ophthalmic practices. The Institute also houses the Lions Eye Bank and the LSSF. |
 |
Headquartered in Basel, Switzerland, Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients, both chemically as well as biotechnologically. |
 |
Merck (known as MSD outside the United States and Canada) is a global healthcare leader working to help the world be well. Through prescription medicines, vaccines, biologic therapies, consumer care and animal health products, Merck works with customers and operates in more than 140 countries to deliver innovative health solutions. |
 |
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, colorectal cancer, and a rare inflammatory condition, and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. |
 |
Virovek is an AAV (adeno-associated virus) production and protein expression services company. Since 2008, Virovek has produced over 700 AAV vectors of the highest quality to support research projects in over 100 privately held companies, university labs, and non-profit institutions worldwide. We currently have satisfied and recurrent customers throughout the United States, as well as in Canada, China, and across Europe. |
